Meta-Analysis Comparing Immediate Versus Staged Complete Revascularization for ST-Elevation Myocardial Infarction With Multivessel Disease

被引:1
作者
Almizel, Abdulrahman M. [1 ]
Levett, Jeremy Y. [2 ]
Zolotarova, Tetiana [3 ]
Eisenberg, Mark J. [1 ,3 ,4 ,5 ,6 ]
机构
[1] McGill Univ, Dept Med, Montreal, PQ, Canada
[2] McGill Univ, Fac Med & Hlth Sci, Dept Surg, Div Cardiac Surg, Montreal, PQ, Canada
[3] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ, Canada
[4] McGill Univ, Fac Med, Montreal, PQ, Canada
[5] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada
[6] McGill Univ, Jewish Gen Hosp, Div Cardiol, Montreal, PQ, Canada
关键词
PERCUTANEOUS CORONARY INTERVENTION; OUTCOMES; VESSEL; IMPACT; TRIAL; TIME;
D O I
10.1016/j.amjcard.2024.12.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with ST-segment elevation myocardial infarction (STEMI) frequently present with multivessel coronary artery disease (CAD) during primary percutaneous coronary intervention, and the optimal timing of complete revascularization (CR) in these cases remains uncertain. This study aims to assess major adverse cardiovascular events (MACEs) and procedural complications in patients with STEMI with multivessel CAD who underwent immediate (index procedure) versus staged CR. We conducted a systematic review and meta-analysis of randomized controlled trials comparing immediate to staged CR in STEMI and multivessel CAD. Trials were identified by way of a systematic search of MEDLINE, Embase, and Cochrane Libraries from database inception to March 6, 2024. The data were analyzed using the RevMan software. A total of 5 randomized controlled trials (n = 1,415) were included in our study, which showed no significant differences in MACEs (13.3% vs 9.8%, relative risk [RR] 1.07, 95% confidence interval [CI] 0.62 to 1.83), all-cause mortality (3% vs 4.55%, RR 0.70, 95% CI 0.41 to 1.21), or myocardial infarction (4.5% vs 2.6%, RR 1.43, 95% CI 0.58 to 3.55) at a weighted mean follow-up duration of 16 months. However, the staged group had a higher rate of unplanned revascularization (8.6% vs 4.4%, RR 1.92, 95% CI 1.21 to 3.04). In conclusion, in patients with STEMI with multivessel CAD, at a mean follow-up of approximately 1.3 years, there is no significant difference in immediate versus staged revascularization (SR) for MACEs; however, SR was associated with a significantly higher incidence of unplanned ischemia-driven revascularization. SR within the index hospitalization may be as effective as immediate CR; further trials are needed to confirm this. We conducted a meta-analysis of 5 randomized controlled trials comparing immediate to staged complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel coronary artery disease. There was no significant difference in major adverse cardiovascular events, all-cause mortality, and myocardial infarction rates between immediate and staged complete revascularization. However, staged revascularization was associated with a higher incidence of unplanned ischemia-driven revascularization. (c) 2024 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/)
引用
收藏
页码:75 / 81
页数:7
相关论文
共 50 条
  • [41] Comprehensive Review of Complete Versus Culprit-only Revascularization for Multivessel Disease in ST-segment Elevation Myocardial Infarction
    Jacob, Robin
    Sachedina, Ayaaz K.
    Kumar, Sachin
    HEART INTERNATIONAL, 2021, 15 (01): : 54 - 59
  • [42] Meta-Analysis of Randomized Controlled Trials Comparing Multivessel Versus Culprit-Only Revascularization for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention
    El-Hayek, Georges E.
    Gershlick, Anthony H.
    Hong, Mun K.
    Dominguez, Abel Casso
    Banning, Amerjeet
    Afshar, Arash Ehteshami
    Herzog, Eyal
    Tamis-Holland, Jacqueline E.
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 115 (11) : 1481 - 1486
  • [43] Culprit-only versus staged complete revascularization for patients with ST-segment elevation myocardial infarction and Multivessel disease: a retrospective cohort study
    Yu, Tongtong
    Dong, Yuanyuan
    Zhu, Jiahe
    Tian, Chunyang
    Sun, Zhijun
    Sun, Zhaoqing
    BMC CARDIOVASCULAR DISORDERS, 2016, 16
  • [44] The optimal timing for intervention in patients with ST-segment elevation myocardial infarction and multivessel disease: a systematic review and meta-analysis
    Chen, Yi
    Li, Meng
    Wu, Yanqing
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [45] ST-elevation Myocardial Infarction and Multivessel Coronary Artery Disease A Critical Review of Current Practice, Evidence and Meta-analyses
    Figini, Filippo
    Chen, Shao Liang
    Sheiban, Imad
    HEART INTERNATIONAL, 2020, 14 (02): : 80 - 85
  • [46] Immediate multivessel revascularization may increase cardiac death and myocardial infarction in patients with ST-elevation myocardial infarction and multivessel coronary artery disease: data analysis from real world practice
    Chung, Woo-Young
    Seo, Jae-Bin
    Choi, Dong-Hyun
    Cho, Young-Seok
    Lee, Joo Myung
    Suh, Jung-Won
    Youn, Tae-Jin
    Chae, In-Ho
    Choi, Dong-Ju
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (03) : 488 - 500
  • [47] Complete Revascularization by Percutaneous Coronary Intervention for Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease: An Updated Meta-Analysis of Randomized Trials
    Ahmad, Yousif
    Howard, James P.
    Arnold, Ahran
    Prasad, Megha
    Seligman, Henry
    Cook, Christopher M.
    Warisawa, Takayuki
    Shun-Shun, Matthew
    Ali, Ziad
    Parikh, Manish A.
    Al-Lamee, Rasha
    Sen, Sayan
    Francis, Darrel
    Moses, Jeffrey W.
    Leon, Martin B.
    Stone, Gregg W.
    Karmpaliotis, Dimitri
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (12):
  • [48] The optimal strategy of percutaneous coronary intervention for ST-elevation myocardial infarction patients with multivessel disease: an updated meta-analysis of 9 randomized controlled trials
    Fan, Zhong-Guo
    Gao, Xiao-Fei
    Li, Xiao-Bo
    Mao, Wen-Xing
    Chen, Li-Wen
    Tian, Nai-Liang
    MINERVA CARDIOANGIOLOGICA, 2017, 65 (02): : 148 - 156
  • [49] Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials
    Pavasini, Rita
    Biscaglia, Simone
    Barbato, Emanuele
    Tebaldi, Matteo
    Dudek, Dariusz
    Escaned, Javier
    Casella, Gianni
    Santarelli, Andrea
    Guiducci, Vincenzo
    Gutierrez-Ibanes, Enrique
    Di Pasquale, Giuseppe
    Politi, Luigi
    Saglietto, Andrea
    D'Ascenzo, Fabrizio
    Campo, Gianluca
    EUROPEAN HEART JOURNAL, 2020, 41 (42) : 4103 - +
  • [50] Optional Revascularization Strategies for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
    Zhong, Peng-Yu
    Sun, Bin
    Cao, Hai -Ping
    Wang, Wei
    Xiong, Ting-Lin
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (06)